Compounds > mifepristone
Page last updated: 2024-08-23

mifepristone and Female Genital Neoplasms

mifepristone has been researched along with Female Genital Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baulieu, EE; Cadepond, F; Ulmann, A1
Koide, SS1

Reviews

2 review(s) available for mifepristone and Female Genital Neoplasms

ArticleYear
RU486 (mifepristone): mechanisms of action and clinical uses.
    Annual review of medicine, 1997, Volume: 48

    Topics: Abortifacient Agents, Steroidal; Clinical Trials as Topic; Female; Genital Neoplasms, Female; Hormone Antagonists; Humans; Infant, Newborn; Male; Menstruation-Inducing Agents; Mifepristone; Neoplasms, Hormone-Dependent; Pregnancy; Receptors, Glucocorticoid; Receptors, Progesterone

1997
Mifepristone. Auxiliary therapeutic use in cancer and related disorders.
    The Journal of reproductive medicine, 1998, Volume: 43, Issue:7

    Topics: Adult; Cushing Syndrome; Endometriosis; Female; Genital Diseases, Female; Genital Neoplasms, Female; Hormone Antagonists; Humans; Mifepristone; Recurrence

1998